Meprobamate and aspirin and Gait hemiplegic - a phase IV clinical study of FDA data
We study 6 people who take Meprobamate and aspirin or have Gait hemiplegic. No report of Gait hemiplegic is found in people who take Meprobamate and aspirin.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Meprobamate And Aspirin?
Meprobamate and aspirin has active ingredients of aspirin; meprobamate.
What is Gait Hemiplegic?
Gait hemiplegic is found to be associated with 17 drugs and 3 conditions by eHealthMe.
Do you take Meprobamate and aspirin and have Gait hemiplegic?Check whether Gait hemiplegic is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Gait hemiplegic and when was it recovered:
Expand to all the drugs that have ingredients of aspirin; meprobamate:
Alternative drugs to, pros and cons of Meprobamate and aspirin:
Gait hemiplegic treatments and more:
- Gait hemiplegic (6 reports)
COVID vaccines that are related to Gait hemiplegic:
- Gait hemiplegic in Moderna COVID Vaccine
- Gait hemiplegic in Pfizer BioNTech Covid Vaccine
- Gait hemiplegic in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Gait hemiplegic:
All the conditions that are associated with Gait hemiplegic:
How the study uses the data?
The study uses data from the FDA. It is based on aspirin; meprobamate (the active ingredients of Meprobamate and aspirin) and Meprobamate and aspirin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Relafen and Coreg drug interaction - now
- Alc and Back Pain - 2 seconds ago
- Venofer and Famotidine drug interaction - 3 seconds ago
- Humatrope and Rickets - 4 seconds ago
- Temaz and Craniocerebral Injury - 5 seconds ago
- Copegus and Peg-Intron drug interaction - 6 seconds ago
- Crixivan and Finasteride drug interaction - 7 seconds ago
- Lorcet-Hd and Hepatic Disorder Aggravated - 12 seconds ago
- Citalopram Hydrobromide and Product Odor Abnormal - 14 seconds ago
- Bumex and Vitreous Floaters - 15 seconds ago